MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014
According to a new market research report, ‘Global Autoimmune Treatment Market (2009–2014)', published by MarketsandMarkets (www.marketsandmarkets.com), the global autoimmune treatment market is expected to be worth US$68.81 billion by 2014, with an estimated CAGR of 12.7% from 2009 to 2014. The North American market is expected to account for nearly 42% of the total revenues.
Browse 100+ market data tables and in-depth TOC on autoimmune treatment market. Early buyers will receive 10% customization of reports
http://www.marketsandmarkets.com/Market-Reports/autoimmune-treatment-market-research-27.html
Autoimmune disorders result from an overactive immune response of a body working against its own cells. The disease is broadly classified into two types: systemic autoimmune diseases, which affect several organs of the body; and localized autoimmune diseases, which affect only one organ. Around 80 autoimmune diseases are recognized under these two categories. The disease affected over 300 million people across the globe in 2009. No defined reasons have been discovered to date for the occurrence of the disorder. Women are more prone to autoimmune diseases, constituting 70%-75% of all autoimmune patients.
The global market for autoimmune disease treatments is estimated to be at $37.84 billion in 2009 and is growing at a CAGR of 12.7% from 2009 to 2014. The market is forecasted to be at $68.81 billion in 2014. The effects of the global meltdown are given careful consideration when forecasting the market. As autoimmune disorders still have no permanent cure, more and more pharmaceutical companies are making significant R&D investments into finding treatments for autoimmune diseases, are also focusing on finding the causes behind the disease, which again are unknown.
The overall market for the treatment of autoimmune disorders is analyzed into the submarkets for applications, products, services, and technologies. The application market is further classified into the treatment markets for systemic autoimmune diseases and localized autoimmune diseases. The applications market is dominated mostly by rheumatoid arthritis under the systemic disease segment, while multiple sclerosis is the major application market under the localized disease segment. These two disorders account for 75% of the total applications market. The other major diseases analysed under the application market are psoriasis, lupus, type I diabetes, inflammatory bowel disease, and thyroid disorders, which together account for 15%-20% of the global applications market.
The product market is classified on the basis of the drugs, diagnostic equipments, therapeutic and monitoring equipment. Drugs form the largest segment of the products market, with major drugs such as NSAID, DMARD, biologic DMARD, Avonex, Rebif, Copaxone, Betaseron, and 5-ASA. The services market consists of consultation and diagnosis, therapy and monitoring, and drug development. The wide and increasing prevalence of autoimmune diseases is boosting the drugs market along with the therapy and monitoring market; along with the fact that almost all autoimmune diseases are chronic and have no permanent cure.
Scope of the Report
- The report provides market overviews, market forecasts, market drivers and restraints for the autoimmune treatment market. In addition, the report profiles the top forty market players and their respective autoimmune products. The report identifies and analyzes the market according to application markets for both systemic and localized autoimmune diseases, product markets, services market, and technologies market.
Autoimmune Treatment – Applications
- Systemic autoimmune diseases – rheumatoid arthritis, psoriasis, lupus and other systemic autoimmune diseases.
- Localized autoimmune diseases – multiple sclerosis, inflammatory bowel disease, diabetes, thyroid and other localized autoimmune diseases.
Autoimmune Treatment – Products
Drugs, diagnostic equipments, therapeutic and monitoring equipments and other products.
Autoimmune Treatment – Services
Consultation & Diagnosis, Therapy & Monitoring, Drug Development and other services.
Autoimmune Treatment – Technologies
DMARD (disease-modifying anti-rheumatic drugs) and biologic DMARD therapy, Bridge therapy, Topical therapy, Phototherapy, Helminthic therapy, Fecal bacteriotherapy, Haematopoietic stem-cell transplantation, Recombinant technology
Analyst Briefings on 15th Sep 2009.
The Pharmaceuticals practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Autoimmune Treatment Market to be held on 15th Sep 2009. The briefing on the Global Autoimmune Treatment Market (2009-2014) will benefit the drug manufacturers, therapeutic and diagnostic equipment manufacturers, researchers and consultation and therapy service providers.
Questions and Answers
Article Tags:
autoimmune treatment market
,research
,market research reports
,market research
,industry analysis
,market share
,market size
Biopharmaceutical products are the key to the future of the pharmaceutical market. Even before the market stagnation seen in 2009 due to the recession, conventional pharmaceuticals were facing drastic consequences from the loss of patent cover for many blockbusters, and the continued failure of the R&D departments in big pharma to produce replacement candidates.
It provides the most up-to-date discussion of the whole biopharma market and explores new clinical indications beyond those already targeted.
Type 2 diabetes has now hit epidemic levels, and is expected to increase further over the coming years with the rise in the age demographic and the escalation in rates of obesity. Currently many type 2 patients are put off using insulin because of its injection delivery and patient compliance a. Thus oral or inhaled insulin would tap into the lucrative type 2 market and encourage further use of insulin. Non-invasive insulin's will address the key unmet need in the diabetes market.
This report analyses and apportions both power and gas volumes and sites in the UK B2B market into Datamonitor's segmentation model.
Datamonitor identified 108 products across all stages of development, but these treatments vary immensely by target.
financial crisis has conned everyone's live. Mass layoffs were happening in everywhere which is very sad. Throughout the crisis era not really a couple of companies go under. This will make the company managers searching for the best and accurate online marketing strategy to enhance the productivity and efficiency of the organization. The best online marketing strategy is really a way to succeed.
Business needs customers to make profit and survive. It's as simple as that. Without doing any marketing no-one knows you exist and you're not going to get too far. So, if you're in serious business, you have to get your message out.
Is your company on the lookout for a plush new office in London? If so there is plenty of different choice as regard areas and plenty of choice when it comes to office space, Lloyd's area of London being a prime example of what is on offer.
The Digital governors are designed not just to take control of the speed of the machine but it also allowed the machine to be smarter, allowing automation and improved functionality for the engine. By implementing these governors, the system became more stabilized and reliable, and there is no more need to add diesel generators that consume precious fuel and is expensive to maintain
If you're heading to Australia for business, you'll discover a world-class destination that's at the cutting edge of many industries. Australia is also ideally located for business opportunities in Asia, and it has a sturdy economy, exceptional facilities, good communication services and strong institutions.Here's just a brief introduction to the essentials for business travellers.
World Sensors Market in Consumer Electronics (2010 -2015) - Market Forecasts by Types & Applications
The global market for sensors in consumer electronics is expected to grow from $10,221 million in 2009 to $22,190 million in 2015. The market is expected to have a high CAGR of 12.44% from 2010 to 2015 due to the increasing demand for sensors in products such as mobile phones, smartphones, game consoles, and laptops.
Service robots can be used to provide domestic aid for the elderly and disabled; serving various functions ranging from cleaning to entertainment.
The best in safety, security and comfort that was originally intended for the etechnologically inclined if is now reaching the general public through smart home. Smart home not only makes daily routine convenient and time saving but also provides energy efficiency.
Cancer is recognized as a major cause of mortality world over; accounting for 7.4 million (or 13%) of all deaths in 2004. The WHO estimates the incidence of cancer to continue rising to reach an estimated 9.2 million deaths in 2015.
Organic light emitting diodes (OLEDs) are self-illuminating flat panel displays where organic materials are stacked between conductors.
Discuss this Article
